Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 6.98
RVP's Cash to Debt is ranked higher than
78% of the 291 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.74 vs. RVP: 6.98 )
RVP' s 10-Year Cash to Debt Range
Min: 0.06   Max: 24.08
Current: 6.98

0.06
24.08
Equity to Asset 0.60
RVP's Equity to Asset is ranked higher than
67% of the 285 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.63 vs. RVP: 0.60 )
RVP' s 10-Year Equity to Asset Range
Min: 0.01   Max: 0.86
Current: 0.6

0.01
0.86
F-Score: 5
Z-Score: 2.69
M-Score: -4.01
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -11.71
RVP's Operating margin (%) is ranked higher than
57% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.44 vs. RVP: -11.71 )
RVP' s 10-Year Operating margin (%) Range
Min: -108.34   Max: -11.71
Current: -11.71

-108.34
-11.71
Net-margin (%) -12.28
RVP's Net-margin (%) is ranked higher than
57% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.65 vs. RVP: -12.28 )
RVP' s 10-Year Net-margin (%) Range
Min: -108.34   Max: 254.12
Current: -12.28

-108.34
254.12
ROE (%) -11.57
RVP's ROE (%) is ranked higher than
58% of the 283 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.68 vs. RVP: -11.57 )
RVP' s 10-Year ROE (%) Range
Min: -4453.7   Max: 85.9
Current: -11.57

-4453.7
85.9
ROA (%) -8.68
RVP's ROA (%) is ranked higher than
58% of the 290 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.24 vs. RVP: -8.68 )
RVP' s 10-Year ROA (%) Range
Min: -50.98   Max: 71.5
Current: -8.68

-50.98
71.5
ROC (Joel Greenblatt) (%) -28.93
RVP's ROC (Joel Greenblatt) (%) is ranked higher than
57% of the 288 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.38 vs. RVP: -28.93 )
RVP' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -87.75   Max: -18.29
Current: -28.93

-87.75
-18.29
Revenue Growth (%) -7.90
RVP's Revenue Growth (%) is ranked higher than
58% of the 248 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. RVP: -7.90 )
RVP' s 10-Year Revenue Growth (%) Range
Min: -7.9   Max: 15.3
Current: -7.9

-7.9
15.3
EBITDA Growth (%) -41.50
RVP's EBITDA Growth (%) is ranked lower than
51% of the 210 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.40 vs. RVP: -41.50 )
RVP' s 10-Year EBITDA Growth (%) Range
Min: -65.8   Max: 224
Current: -41.5

-65.8
224
EPS Growth (%) -25.00
RVP's EPS Growth (%) is ranked higher than
55% of the 220 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.90 vs. RVP: -25.00 )
RVP' s 10-Year EPS Growth (%) Range
Min: -35.6   Max: 56.5
Current: -25

-35.6
56.5
» RVP's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with RVP



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 3.20
RVP's P/B is ranked higher than
54% of the 278 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.77 vs. RVP: 3.20 )
RVP' s 10-Year P/B Range
Min: 0.27   Max: 17.05
Current: 3.2

0.27
17.05
P/S 3.10
RVP's P/S is ranked lower than
53% of the 292 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.60 vs. RVP: 3.10 )
RVP' s 10-Year P/S Range
Min: 0.39   Max: 9.19
Current: 3.1

0.39
9.19
PFCF 23.30
RVP's PFCF is ranked higher than
70% of the 164 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.00 vs. RVP: 23.30 )
RVP' s 10-Year PFCF Range
Min: 1.29   Max: 79
Current: 23.3

1.29
79
EV-to-EBIT 2.20
RVP's EV-to-EBIT is ranked higher than
97% of the 247 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.32 vs. RVP: 2.20 )
RVP' s 10-Year EV-to-EBIT Range
Min: 0   Max: 0
Current: 2.2

Valuation & Return

vs
industry
vs
history
Price/Net Cash 13.00
RVP's Price/Net Cash is ranked higher than
59% of the 68 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 17.30 vs. RVP: 13.00 )
RVP' s 10-Year Price/Net Cash Range
Min: 1.2   Max: 424.5
Current: 13

1.2
424.5
Price/Net Current Asset Value 6.80
RVP's Price/Net Current Asset Value is ranked higher than
69% of the 118 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 13.00 vs. RVP: 6.80 )
RVP' s 10-Year Price/Net Current Asset Value Range
Min: 0.89   Max: 628
Current: 6.8

0.89
628
Price/Tangible Book 3.30
RVP's Price/Tangible Book is ranked higher than
68% of the 232 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. RVP: 3.30 )
RVP' s 10-Year Price/Tangible Book Range
Min: 0.46   Max: 785
Current: 3.3

0.46
785
Price/DCF (Projected) 6.20
RVP's Price/DCF (Projected) is ranked lower than
79% of the 147 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.40 vs. RVP: 6.20 )
RVP' s 10-Year Price/DCF (Projected) Range
Min: 0.19   Max: 45
Current: 6.2

0.19
45
Price/Median PS Value 2.10
RVP's Price/Median PS Value is ranked lower than
69% of the 268 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.10 vs. RVP: 2.10 )
RVP' s 10-Year Price/Median PS Value Range
Min: 0.41   Max: 12.87
Current: 2.1

0.41
12.87
Forward Rate of Return (Yacktman) -2.42
RVP's Forward Rate of Return (Yacktman) is ranked higher than
65% of the 217 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. RVP: -2.42 )
RVP' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 0   Max: 0
Current: -2.42

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Retractable Technologies, Inc. was incorporated in Texas on May 9, 1994. The Company designs, develops, manufactures, and markets innovative patented safety medical products for the healthcare industry. The Company's products with Notice of Substantial Equivalence to the U.S. Food and Drug Administration (FDA) and which are currently sold include the 1mL tuberculin; insulin; allergy antigen VanishPoint syringes; 3mL, 5mL, and 10mL VanishPoint syringes; the VanishPoint blood collection tube holder; the VanishPoint IV safety catheter; small diameter tube adapter; the Patient Safe syringe; the Patient Safe Luer Cap; and the VanishPoint Blood Collection Set. It is also selling autodisable syringes in the international market. The Company's VanishPoint safety products (consisting of 1mL tuberculin, insulin, and allergy antigen VanishPoint syringes; 0.5mL, 3mL, 5mL, and 10mL VanishPoint syringes; the VanishPoint blood collection tube holder; autodisable syringe; the VanishPoint IV safety catheter; and the VanishPoint Blood Collection Set) utilize a unique friction ring mechanism. The friction ring mechanism permits the automated retraction of the syringe needle into the barrel of the syringe, directly from the patient, after delivery of the medication is completed. The VanishPoint blood collection tube holder utilizes the same mechanism to retract the needle after blood has been drawn from the patient. Closure of an attached end cap of the blood collection tube holder causes the needle to retract directly from the patient into the closed blood collection tube holder. The IV catheter also operates with a friction ring mechanism whereby the needle is retracted after insertion of the catheter into the patient. It also has a Patient Safe syringe which reduces the risk of infection resulting from IV line contamination. Advantages of its VanishPoint safety needle products include protection from needlestick injuries, prevention of cross contamination through reuse, and reduction of disposal and other associated costs. Federal regulation now requires the use of safe needle devices. The Company distributes its products throughout the U.S. and its territories through general line and specialty distributors. It also has trademark protection for the phrase 'The New Standard for Safety'.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide